Patients Overseas doctors are keeping the NHS alive: It’s time we sto... As a loud minority pushes Britain towards devolved nationalism, it’s worth remembering this sobering truth: without immigrants, there would be no NHS.
R&D Changing Faces: Pharma and biotech November-December 2024 Welcome to the last edition of Changing Faces for 2024.
Sales & Marketing Revitalising life sciences hiring: The case for creative rec... The labour market in the life sciences sector has stabilised, but employers are still finding it challenging to attract the best talent.
Market Access Balancing innovation and safety: The impact of Medtech regul... The Medtech sector is currently at a crossroads, facing a potential choice between rapid technological advancement and strict regulatory oversight.
Sales & Marketing Changing Faces: Agency, consultancy, and investor hires from... Another light month in March on the agency and investor side, but there are a few appointments worth noting.
Digital Changing Faces: Digital and supplier hires from March 2024 We’re back with another hires round-up for digital health companies and pharma suppliers. There was plenty of action across the sector in March.
News EMA advisors say CSL's Tavneos should be pulled from sale Pressure is building on Amgen to withdraw rare disease therapy Tavneos, after the CHMP recommended its marketing authorisation by revoked in the EU.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.